← Back
$QNCX All transactions

Quince Therapeutics, Inc.

A

$ Value

$0

Shares

365,000

Price

$0

Filed

Jan 23

Insider

Name

Hannah Brendan

Title

CBO, COO & CCO

CIK

0001929422

Roles

Officer

Transaction Details

Transaction Date

2026-01-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

365,000

Footnotes

The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting with 1/48th vesting on the date of grant and the remaining options vesting on the 1st day of each subsequent month, such that the total number of shares shall be fully vested on December 1, 2029.

Filing Info

Accession No.

0000912282-26-000119

Form Type

4

Issuer CIK

0001662774

Hannah Brendan's History

Date Ticker Type Value
2026-01-23 QNCX A $0
2025-12-05 QNCX M $1K
2025-12-05 QNCX M $24K
2025-12-05 QNCX M $0
2025-12-05 QNCX M $0
2025-06-18 QNCX A $45K
2025-06-18 QNCX A $5K

Other Insiders at QNCX (90d)

No other insider activity at this issuer in the last 90 days.